205 related articles for article (PubMed ID: 33247919)
1. Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients.
Pappas II; Craig WY; Spratt LV; Spratt DI
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1290-e1300. PubMed ID: 33247919
[TBL] [Abstract][Full Text] [Related]
2. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients.
Spratt DI; Stewart II; Savage C; Craig W; Spack NP; Chandler DW; Spratt LV; Eimicke T; Olshan JS
J Clin Endocrinol Metab; 2017 Jul; 102(7):2349-2355. PubMed ID: 28379417
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
5. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals.
Ott J; Aust S; Promberger R; Huber JC; Kaufmann U
J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834
[TBL] [Abstract][Full Text] [Related]
6. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
[TBL] [Abstract][Full Text] [Related]
7. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
8. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
Liang JJ; Jolly D; Chan KJ; Safer JD
Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
[TBL] [Abstract][Full Text] [Related]
9. Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey.
Karakılıç Özturan E; Öztürk AP; Baş F; Erdoğdu AB; Kaptan S; Kardelen Al AD; Poyrazoğlu Ş; Yıldız M; Direk N; Yüksel Ş; Darendeliler F
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):276-284. PubMed ID: 36987788
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis.
Singh-Ospina N; Maraka S; Rodriguez-Gutierrez R; Davidge-Pitts C; Nippoldt TB; Prokop LJ; Murad MH
J Clin Endocrinol Metab; 2017 Nov; 102(11):3904-3913. PubMed ID: 28945851
[TBL] [Abstract][Full Text] [Related]
11. METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS.
Fernandez JD; Tannock LR
Endocr Pract; 2016 Apr; 22(4):383-8. PubMed ID: 26574790
[TBL] [Abstract][Full Text] [Related]
12. Cross-sex hormone administration changes pain in transsexual women and men.
Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
[TBL] [Abstract][Full Text] [Related]
13. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
[TBL] [Abstract][Full Text] [Related]
14. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis.
Maraka S; Singh Ospina N; Rodriguez-Gutierrez R; Davidge-Pitts CJ; Nippoldt TB; Prokop LJ; Murad MH
J Clin Endocrinol Metab; 2017 Nov; 102(11):3914-3923. PubMed ID: 28945852
[TBL] [Abstract][Full Text] [Related]
15. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
Gooren LJ; van Trotsenburg MA; Giltay EJ; van Diest PJ
J Sex Med; 2013 Dec; 10(12):3129-34. PubMed ID: 24010586
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of youth with gender dysphoria in Vancouver.
Khatchadourian K; Amed S; Metzger DL
J Pediatr; 2014 Apr; 164(4):906-11. PubMed ID: 24315505
[TBL] [Abstract][Full Text] [Related]
18. Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center.
Reisner SL; Vetters R; White JM; Cohen EL; LeClerc M; Zaslow S; Wolfrum S; Mimiaga MJ
AIDS Care; 2015; 27(8):1031-6. PubMed ID: 25790139
[TBL] [Abstract][Full Text] [Related]
19. Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging.
Spies M; Hahn A; Kranz GS; Sladky R; Kaufmann U; Hummer A; Ganger S; Kraus C; Winkler D; Seiger R; Comasco E; Windischberger C; Kasper S; Lanzenberger R
Neuroimage; 2016 Sep; 138():257-265. PubMed ID: 27236082
[TBL] [Abstract][Full Text] [Related]
20. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration.
Seiger R; Hahn A; Hummer A; Kranz GS; Ganger S; Woletz M; Kraus C; Sladky R; Kautzky A; Kasper S; Windischberger C; Lanzenberger R
Psychoneuroendocrinology; 2016 Dec; 74():371-379. PubMed ID: 27744092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
